Biopharmaceuticals
Biopharmaceutics Risk AssessmentâConnecting Critical Bioavailability Attributes with In Vitro, In Vivo Properties and Physiologically Based Biopharmaceutics Modeling to Enable Generic Regulatory Submissions
Biopharmaceutical benchmarks
Biopharmaceutics
BIOPHARMACEUTICALS
Establishing the Bioequivalence Safe Space for Immediate-Release Oral Dosage Forms using Physiologically Based Biopharmaceutics Modeling (PBBM): Case Studies
Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary Report
pH-Dependent Solubility and Permeability Criteria for Provisional Biopharmaceutics Classification (BCS and BDDCS) in Early Drug Discovery
Centrifugal Lithography: SelfâShaping of Polymer Microstructures Encapsulating Biopharmaceutics by Centrifuging Polymer Drops